Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks

Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks

<b>(1) Background:</b> Prurigo nodularis (PN) is a persistent and inflammatory dermatological condition characterized by chronic itching and the formation of hardened nodules, significantly impacting the affected individuals’ quality of life and psychological well-being. The management o...

Full description

Bibliographic Details
Main Authors: Claudia Paganini, Marina Talamonti, Virginia Maffei, Cosimo Di Raimondo, Luca Bianchi, Marco Galluzzo
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Clinical Medicine
Subjects:
prurigo nodularis
dupilumab
atopic dermatitis
Online Access:https://www.mdpi.com/2077-0383/13/3/878

Internet

https://www.mdpi.com/2077-0383/13/3/878

Similar Items